Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is a biotechnology company dedicated to the research, development and commercialization of pharmaceuticals for the treatment and cure of Alzheimerâs disease. Alzamend Neuro⢠is currently working to transition two therapeutics targeting Alzheimerâs disease (âADâ) from the research and preclinical stage at the University of South Florida into the clinical stage and towards full commercialization. Alzamend Neuro⢠has licensed both a patented mutant-peptide immunotherapeutic (CAO22W) for use as a treatment or vaccine and a lithium based ionic cocrystal therapy (LiProSalâ˘) that may greatly reduce or eliminate the symptoms of agitation and other endpoints for mild to moderate stage patients diagnosed with AD. There are no profound treatments today for Alzheimerâs disease. With CAO22W and LiProSalâ˘, the Company believes that Alzamend⢠can change that.
No articles found.
We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...
We are rapidly translating our specific, effici...
Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune ...
Cellectis is a clinical-stage biopharmaceutical...
Cellect Biotechnology Ltd. was founded in 2011 by Kasbian Nuriel Chirich, Dr. Shai...
Cellect Biotechnology Ltd. was founded in 2011 ...
TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed...
TherapeuticsMD, Inc. is an innovative pharmaceu...
Chimerix is a development-stage biopharmaceutical company dedicated to acceleratin...
Chimerix is a development-stage biopharmaceutic...
We exist to make the first step in a familys path to recovery the right step thro...
We exist to make the first step in a familys p...
CARROT is a fitness app that rewards users financially for walking and meeting per...
CARROT is a fitness app that rewards users fina...
ManeGain is a U.S.-based start-up, marketing a non-invasive hair therapy and exclu...
ManeGain is a U.S.-based start-up, marketing a ...
Our current primary focus verticals are the US human and pet wellness CBD market a...
Our current primary focus verticals are the US ...
Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...
Intra-Cellular Therapies is a biopharmaceutical...
Join the National Investor Network and get the latest information with your interests in mind.